Literature DB >> 15650181

Capped RNA transcripts of full-length cDNA clones of swine hepatitis E virus are replication competent when transfected into Huh7 cells and infectious when intrahepatically inoculated into pigs.

Y W Huang1, G Haqshenas, C Kasorndorkbua, P G Halbur, S U Emerson, X J Meng.   

Abstract

Swine hepatitis E virus (swine HEV), the first animal strain of HEV to be isolated, is a zoonotic agent. We report here the construction and in vitro and in vivo characterizations of infectious cDNA clones of swine HEV. Eight overlapping fragments spanning the entire genome were amplified by reverse transcription-PCR and assembled into a full-length cDNA clone, clone C, which contained 14 mutations compared to the consensus sequence of swine HEV. RNA transcripts from clone C were not infectious, as determined by intrahepatic inoculation into pigs and by in vitro transfection of Huh7 cells. Multiple site-based site-directed mutagenesis was performed to generate three new cDNA clones (pSHEV-1, pSHEV-2, and pSHEV-3) which differed from each other. The transfection of capped RNA transcripts into human liver Huh7 cells resulted in the synthesis of both ORF2 capsid and ORF3 proteins, indicating that the cDNA clones were replication competent. Each of the three clones resulted in active swine HEV infections after the intrahepatic inoculation of pigs with capped RNA transcripts. The patterns of seroconversion, viremia, and fecal virus shedding for pigs inoculated with RNA transcripts from clones pSHEV-2 and pSHEV-3 were similar to each other and to those for pigs inoculated with wild-type swine HEV, suggesting that the nucleotide differences between these two cDNA clones were not critical for replication. Pigs inoculated with RNA transcripts from clone pSHEV-1, which contained three nonsilent mutations in the ORF2 capsid gene, had a delayed appearance of seroconversion and fecal virus shedding and had undetectable viremia. The availability of these infectious cDNA clones affords us an opportunity to understand the mechanisms of cross-species infection by constructing chimeric human and swine HEVs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15650181      PMCID: PMC544089          DOI: 10.1128/JVI.79.3.1552-1558.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  Determination of the nucleotide sequences at the extreme 5' and 3' ends of swine hepatitis E virus genome.

Authors:  G Haqshenas; X J Meng
Journal:  Arch Virol       Date:  2001-12       Impact factor: 2.574

2.  Alteration of amino acids in VP2 of very virulent infectious bursal disease virus results in tissue culture adaptation and attenuation in chickens.

Authors:  A A W M van Loon; N de Haas; I Zeyda; E Mundt
Journal:  J Gen Virol       Date:  2002-01       Impact factor: 3.891

3.  Use of a swine bioassay and a RT-PCR assay to assess the risk of transmission of swine hepatitis E virus in pigs.

Authors:  C Kasorndorkbua; P G Halbur; P J Thomas; D K Guenette; T E Toth; X J Meng
Journal:  J Virol Methods       Date:  2002-03       Impact factor: 2.014

4.  Acute hepatitis caused by a novel strain of hepatitis E virus most closely related to United States strains.

Authors:  Yamina Kabrane-Lazizi; Mingdong Zhang; Robert H Purcell; Kirk D Miller; Richard T Davey; Suzanne U Emerson
Journal:  J Gen Virol       Date:  2001-07       Impact factor: 3.891

5.  Hepatitis E virus antibody prevalence among persons who work with swine.

Authors:  J Drobeniuc; M O Favorov; C N Shapiro; B P Bell; E E Mast; A Dadu; D Culver; P Iarovoi; B H Robertson; H S Margolis
Journal:  J Infect Dis       Date:  2001-12-03       Impact factor: 5.226

6.  Recombinant hepatitis E virus genomes infectious for primates: importance of capping and discovery of a cis-reactive element.

Authors:  S U Emerson; M Zhang; X J Meng; H Nguyen; M St Claire; S Govindarajan; Y K Huang; R H Purcell
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-11       Impact factor: 11.205

7.  Evidence for widespread infection of wild rats with hepatitis E virus in the United States.

Authors:  Y Kabrane-Lazizi; J B Fine; J Elm; G E Glass; H Higa; A Diwan; C J Gibbs; X J Meng; S U Emerson; R H Purcell
Journal:  Am J Trop Med Hyg       Date:  1999-08       Impact factor: 2.345

8.  Prevalence of antibodies to hepatitis E virus in veterinarians working with swine and in normal blood donors in the United States and other countries.

Authors:  X J Meng; B Wiseman; F Elvinger; D K Guenette; T E Toth; R E Engle; S U Emerson; R H Purcell
Journal:  J Clin Microbiol       Date:  2002-01       Impact factor: 5.948

9.  Identification and characterization of the neutralization epitope(s) of the hepatitis E virus.

Authors:  J Meng; X Dai; J C Chang; E Lopareva; J Pillot; H A Fields; Y E Khudyakov
Journal:  Virology       Date:  2001-09-30       Impact factor: 3.616

Review 10.  Hepatitis E virus.

Authors:  Suzanne U Emerson; Robert H Purcell
Journal:  Rev Med Virol       Date:  2003 May-Jun       Impact factor: 6.989

View more
  31 in total

1.  ORF3 protein of hepatitis E virus is not required for replication, virion assembly, or infection of hepatoma cells in vitro.

Authors:  Suzanne U Emerson; Hanh Nguyen; Udana Torian; Robert H Purcell
Journal:  J Virol       Date:  2006-08-23       Impact factor: 5.103

2.  Initiation at the third in-frame AUG codon of open reading frame 3 of the hepatitis E virus is essential for viral infectivity in vivo.

Authors:  Y W Huang; T Opriessnig; P G Halbur; X J Meng
Journal:  J Virol       Date:  2007-01-03       Impact factor: 5.103

3.  New Methods in Tissue Engineering: Improved Models for Viral Infection.

Authors:  Vyas Ramanan; Margaret A Scull; Timothy P Sheahan; Charles M Rice; Sangeeta N Bhatia
Journal:  Annu Rev Virol       Date:  2014-11       Impact factor: 10.431

4.  Intergenotypic chimeric hepatitis E viruses (HEVs) with the genotype 4 human HEV capsid gene in the backbone of genotype 3 swine HEV are infectious in pigs.

Authors:  Alicia R Feagins; Laura Córdoba; Brent J Sanford; Barbara A Dryman; Yao-Wei Huang; Tanya LeRoith; Suzanne U Emerson; Xiang-Jin Meng
Journal:  Virus Res       Date:  2010-12-30       Impact factor: 3.303

Review 5.  Enterically Transmitted Non-A, Non-B Hepatitis and the Discovery of Hepatitis E Virus.

Authors:  Stanley M Lemon; Christopher M Walker
Journal:  Cold Spring Harb Perspect Med       Date:  2019-08-01       Impact factor: 6.915

6.  Three amino acid mutations (F51L, T59A, and S390L) in the capsid protein of the hepatitis E virus collectively contribute to virus attenuation.

Authors:  Laura Córdoba; Yao-Wei Huang; Tanja Opriessnig; Kylie K Harral; Nathan M Beach; Carla V Finkielstein; Suzanne U Emerson; Xiang-Jin Meng
Journal:  J Virol       Date:  2011-03-30       Impact factor: 5.103

7.  Development and validation of a negative-strand-specific reverse transcription-PCR assay for detection of a chicken strain of hepatitis E virus: identification of nonliver replication sites.

Authors:  P Billam; F W Pierson; W Li; T LeRoith; R B Duncan; X J Meng
Journal:  J Clin Microbiol       Date:  2008-06-18       Impact factor: 5.948

Review 8.  Naturally occurring animal models of human hepatitis E virus infection.

Authors:  Danielle M Yugo; Caitlin M Cossaboom; Xiang-Jin Meng
Journal:  ILAR J       Date:  2014

9.  Hepatitis E virus genotype 1 infection of swine kidney cells in vitro is inhibited at multiple levels.

Authors:  H T Nguyen; P Shukla; U Torian; K Faulk; S U Emerson
Journal:  J Virol       Date:  2013-11-06       Impact factor: 5.103

10.  Rescue of a genotype 4 human hepatitis E virus from cloned cDNA and characterization of intergenotypic chimeric viruses in cultured human liver cells and in pigs.

Authors:  Laura Córdoba; Alicia R Feagins; Tanja Opriessnig; Caitlin M Cossaboom; Barbara A Dryman; Yao-Wei Huang; Xiang-Jin Meng
Journal:  J Gen Virol       Date:  2012-07-25       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.